Geneva, Switzerland

Jean-Paul Giacobino

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Energesis Pharmaceuticals, Inc., Novartis Ag, The United States as Represented by the Secretary of the Department of. Active years: 1995-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Paul Giacobino. Retrieved from https://idiyas.com/inventor/jean-paul-giacobino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Genève, CH (2003)
  • Geneva, CH (1995 - 2024)

Company Filing History:


Years Active: 1995-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Jean-Paul Giacobino

Introduction

Jean-Paul Giacobino is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of metabolic diseases through his innovative research and patents. With a total of seven patents to his name, Giacobino's work focuses on brown adipose tissue and its potential applications in treating various health conditions.

Latest Patents

One of Giacobino's latest patents involves brown adipocyte progenitors in human skeletal muscle. This invention provides methods for identifying brown adipose tissue (BAT) progenitor cells and inducing their differentiation into brown adipocytes. The patent also outlines methods for increasing the activity levels of BAT uncoupling protein-1 (UCP1). These differentiated brown adipocytes and the agents that induce their differentiation can be utilized in the treatment of metabolic diseases such as obesity, type 2 diabetes, and cardiovascular diseases. Additionally, the invention addresses the prevention of hypothermia through the use of BAT progenitor cells.

Career Highlights

Throughout his career, Giacobino has worked with prominent companies in the pharmaceutical industry, including Energesis Pharmaceuticals, Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in metabolic research and innovation.

Collaborations

Giacobino has collaborated with notable professionals in his field, including Olivier D. Boss and Mihaela Crisan. These collaborations have further enhanced his research and development efforts in the area of brown adipose tissue.

Conclusion

Jean-Paul Giacobino's innovative work in the field of metabolic diseases highlights the importance of research in developing effective treatments. His contributions through patents and collaborations continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…